<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">25111022</PMID>
      <DateCompleted>
        <Year>2016</Year>
        <Month>01</Month>
        <Day>18</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2017</Year>
        <Month>11</Month>
        <Day>16</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1769-7123</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>166</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2015</Year>
              <Month>May</Month>
            </PubDate>
          </JournalIssue>
          <Title>Research in microbiology</Title>
          <ISOAbbreviation>Res Microbiol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Genomics of Clostridium botulinum group III strains.</ArticleTitle>
        <Pagination>
          <StartPage>318</StartPage>
          <EndPage>325</EndPage>
          <MedlinePgn>318-25</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.resmic.2014.07.016</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S0923-2508(14)00118-1</ELocationID>
        <Abstract>
          <AbstractText>In Clostridium botulinum, the characteristics of type C and D strains are quite different from other types, and they are classified as group III. They produce C2 binary toxin and C3 exoenzyme in addition to type C and D neurotoxins. Two different phages and many plasmids are identified in the organisms. The genes of neurotoxin and C3 exoenzyme are converted from toxigenic strains to non-toxigenic strains by the specific bacteriophages (phages), whereas, the C2 toxin gene is carried by large or small plasmids. Classification of type C and D strains has been in confusion because 1) antigenicity of type C and D neurotoxins is complex, 2) the cells produce two types of toxins, neurotoxin and C2 toxin, and 3) some non-toxigenic strains can be converted to produce C or D neurotoxin by the infection with phages. Until now, entire nucleotide sequences of cell chromosomes, phages, and plasmids have been determined. Since both genetic and protein-chemical analyses have been clarifying the above confusions, these data are reviewed historically.</AbstractText>
          <CopyrightInformation>Copyright Â© 2014 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Sakaguchi</LastName>
            <ForeName>Yoshihiko</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Interdisciplinary Research Organization, University of Miyazaki, 1-1 Gakuenkibanadainishi, Miyazaki 889-2192, Japan. Electronic address: ysakaguc@med.miyazaki-u.ac.jp.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Suzuki</LastName>
            <ForeName>Tomonori</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Applied Biosciences, Department of Nutritional Science and Food Safety, Tokyo University of Agriculture, 1-1-1 Sakuragaoka, Setagaya-ku, Tokyo 156-8502, Japan. Electronic address: ts200588@nodai.ac.jp.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yamamoto</LastName>
            <ForeName>Yumiko</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Bacteriology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 2-3-5 Shikata-cyo, Kita-ku, Okayama 700-8558, Japan. Electronic address: yumiya@md.okayama-u.ac.jp.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nishikawa</LastName>
            <ForeName>Atsushi</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Applied Biological Science, Tokyo University of Agriculture and Technology, 3-5-8 Saiwai-cho, Fuchu, Tokyo 183-8509, Japan. Electronic address: nishikaw@cc.tuat.ac.jp.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Oguma</LastName>
            <ForeName>Keiji</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Bacteriology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 2-3-5 Shikata-cyo, Kita-ku, Okayama 700-8558, Japan; Hakodate Internal Medicine-Hospital, 24-5 Hanazono-cyo, Hakodate 041-0843, Japan. Electronic address: kuma@md.okayama-u.ac.jp.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2014</Year>
          <Month>08</Month>
          <Day>09</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>France</Country>
        <MedlineTA>Res Microbiol</MedlineTA>
        <NlmUniqueID>8907468</NlmUniqueID>
        <ISSNLinking>0923-2508</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>331HTW151K</RegistryNumber>
          <NameOfSubstance UI="C096325">botulinum toxin type D</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 3.4.24.69</RegistryNumber>
          <NameOfSubstance UI="D001905">Botulinum Toxins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>FPM7829VMX</RegistryNumber>
          <NameOfSubstance UI="C096324">botulinum toxin type C</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D001435" MajorTopicYN="N">Bacteriophages</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001905" MajorTopicYN="N">Botulinum Toxins</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003014" MajorTopicYN="N">Clostridium botulinum</DescriptorName>
          <QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016680" MajorTopicYN="Y">Genome, Bacterial</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D023281" MajorTopicYN="Y">Genomics</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010957" MajorTopicYN="N">Plasmids</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011499" MajorTopicYN="N">Protein Processing, Post-Translational</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">C2 toxin</Keyword>
        <Keyword MajorTopicYN="N">C3 exoenzyme</Keyword>
        <Keyword MajorTopicYN="N">Clostridium botulinum group III</Keyword>
        <Keyword MajorTopicYN="N">Neurotoxin</Keyword>
        <Keyword MajorTopicYN="N">Phage conversion</Keyword>
        <Keyword MajorTopicYN="N">Progenitor toxin</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2014</Year>
          <Month>7</Month>
          <Day>23</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2014</Year>
          <Month>7</Month>
          <Day>30</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2014</Year>
          <Month>8</Month>
          <Day>12</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2014</Year>
          <Month>8</Month>
          <Day>12</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2016</Year>
          <Month>1</Month>
          <Day>19</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">25111022</ArticleId>
        <ArticleId IdType="doi">10.1016/j.resmic.2014.07.016</ArticleId>
        <ArticleId IdType="pii">S0923-2508(14)00118-1</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
